Dear Dr. Roach: I am a 68-year-old male in good health who exercises regularly, doesn't take any medications, and doesn't have a family history of prostate cancer. During my most recent yearly ...
Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...
Here’s a PSA about PSA—meaning a public service announcement about prostate specific antigen. Although checking the PSA levels in your blood is a routine way of screening for prostate cancer, just ...
Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
News that former President Joseph Biden has advanced prostate cancer has revived long-standing questions about the benefits versus the harms of a blood test that screens for the most commonly ...
In real-world patients with mHSPC, a PSA cutoff of 0.2 ng/mL after 6 to 12 months of intensified hormone therapy predicts survival outcomes. An absolute PSA level of 0.2 ng/mL or more at 6 to 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results